• Conduct of Clinical Trials of Medical Products during the COVID-19 Public Health Emergency (updated Guidance, dated 27 Janury 2021)
• E-signatures clarified in FDA’s COVID-19 clinical trial guidance
• “FDA COVID-19 Response” (14 April 2020)
• “FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Pandemic”